Annual Cash & Cash Equivalents
$24.84 M
+$8.39 M+51.01%
March 31, 2023
Summary
- As of March 6, 2025, MDNA annual cash & cash equivalents is $24.84 million, with the most recent change of +$8.39 million (+51.01%) on March 31, 2023.
- During the last 3 years, MDNA annual cash & cash equivalents has risen by +$8.83 million (+55.19%).
Performance
MDNA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$22.35 M
-$2.49 M-10.03%
June 30, 2023
Summary
- As of March 6, 2025, MDNA quarterly cash and cash equivalents is $22.35 million, with the most recent change of -$2.49 million (-10.03%) on June 30, 2023.
- Over the past year, MDNA quarterly cash and cash equivalents has stayed the same.
Performance
MDNA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MDNA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.0% | 0.0% |
| 3 y3 years | +55.2% | 0.0% |
| 5 y5 years | +714.4% | 0.0% |
MDNA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -33.8% | -23.6% | -33.0% |
| 5 y | 5-year | at high | -92.9% | -23.6% | -76.1% |
| alltime | all time | at high | -97.5% | -23.6% | -98.3% |
Medicenna Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $22.35 M(-10.0%) |
| Mar 2023 | $24.84 M(+51.0%) | $24.84 M(-6.8%) |
| Dec 2022 | - | $26.64 M(-8.9%) |
| Sep 2022 | - | $29.26 M(+95.3%) |
| Jun 2022 | - | $14.98 M(-8.9%) |
| Mar 2022 | $16.45 M(-31.6%) | $16.45 M(-10.3%) |
| Dec 2021 | - | $18.35 M(+40.2%) |
| Sep 2021 | - | $13.08 M(-37.4%) |
| Jun 2021 | - | $20.89 M(-13.2%) |
| Mar 2021 | $24.06 M(+50.4%) | $24.06 M(+32.0%) |
| Dec 2020 | - | $18.22 M(+0.9%) |
| Sep 2020 | - | $18.07 M(+133.5%) |
| Jun 2020 | - | $7.74 M(-51.7%) |
| Mar 2020 | $16.00 M | $16.00 M(+199.8%) |
| Dec 2019 | - | $5.34 M(+257.0%) |
| Sep 2019 | - | $1.50 M(+85.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $805.50 K(-54.6%) |
| Mar 2019 | $1.78 M(-41.8%) | $1.78 M(-47.9%) |
| Dec 2018 | - | $3.41 M(+211.6%) |
| Sep 2018 | - | $1.09 M(-8.7%) |
| Jun 2018 | - | $1.20 M(-60.7%) |
| Mar 2018 | $3.05 M(-71.0%) | $3.05 M(-40.1%) |
| Dec 2017 | - | $5.09 M(-33.6%) |
| Sep 2017 | - | $7.67 M(-17.1%) |
| Jun 2017 | - | $9.25 M(-12.1%) |
| Mar 2017 | $10.53 M(+155.9%) | $10.53 M(+173.7%) |
| Dec 2016 | - | $3.85 M(+534.5%) |
| Sep 2016 | - | $606.20 K(-2.0%) |
| Jun 2016 | - | $618.50 K(-2.9%) |
| Mar 2016 | $4.11 M(+573.3%) | $636.90 K(-1.2%) |
| Dec 2015 | $610.90 K | - |
| Sep 2015 | - | $644.80 K(+70.6%) |
| Jun 2015 | - | $378.00 K |
FAQ
- What is Medicenna Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual cash & cash equivalents year-on-year change?
- What is Medicenna Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Medicenna Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of MDNA is $24.84 M
What is the all time high annual cash & cash equivalents for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual cash & cash equivalents is $24.84 M
What is Medicenna Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, MDNA annual cash & cash equivalents has changed by +$8.39 M (+51.01%)
What is Medicenna Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MDNA is $22.35 M
What is the all time high quarterly cash and cash equivalents for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly cash and cash equivalents is $29.26 M
What is Medicenna Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, MDNA quarterly cash and cash equivalents has changed by $0.00 (0.00%)